Insider · CIK 0001626003

Cohen Yuval

Reports to the SEC for 1 company · NORWOOD, MA

sec.gov

Transactions

Companies

Filings

CIK

0001626003

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-07	CRBPCorbus Pharmaceuticals Holdings, Inc.S Sale	Director, Chief Executive Officer	SSale	−17K sh	$10.08	−$171K	157,316
2026-02-13	CRBPCorbus Pharmaceuticals Holdings, Inc.S Sale	Director, Chief Executive Officer	SSale	−13.9K sh	$7.78	−$108K	174,316
2026-01-14	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock options (right to buy)A Award	Director, Chief Executive Officer	AAward	+150K sh	—	—	150,000
2026-01-14	CRBPCorbus Pharmaceuticals Holdings, Inc.A Award	Director, Chief Executive Officer	AAward	+50K sh	—	—	188,187
2025-10-27	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock options (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−8,973 sh	—	—	22,106
2025-10-27	CRBPCorbus Pharmaceuticals Holdings, Inc.S Sale	Director, Chief Executive Officer	SSale	−8,973 sh	$17.14	−$154K	138,187
2025-10-27	CRBPCorbus Pharmaceuticals Holdings, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+8,973 sh	$4.26	+$38.2K	147,160
2025-10-24	CRBPCorbus Pharmaceuticals Holdings, Inc.S Sale	Director, Chief Executive Officer	SSale	−18.7K sh	$17.01	−$317K	138,187
2025-10-24	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock options (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−18.7K sh	—	—	31,079
2025-10-24	CRBPCorbus Pharmaceuticals Holdings, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+18.7K sh	$4.26	+$79.5K	156,847
2025-02-14	CRBPCorbus Pharmaceuticals Holdings, Inc.S Sale	Director, Chief Executive Officer	SSale	−7,134 sh	$8.76	−$62.5K	138,187
2025-01-31	CRBPCorbus Pharmaceuticals Holdings, Inc.A Award	Director, Chief Executive Officer	AAward	+68.1K sh	—	—	145,321
2025-01-31	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock options (right to buy)A Award	Director, Chief Executive Officer	AAward	+229K sh	—	—	228,800
2024-06-18	CRBPCorbus Pharmaceuticals Holdings, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+11.7K sh	$30.00	+$350K	96,067
2024-06-18	CRBPCorbus Pharmaceuticals Holdings, Inc.S Sale	Director, Chief Executive Officer	SSale	−11.7K sh	$42.24	−$493K	84,400
2024-06-18	CRBPCorbus Pharmaceuticals Holdings, Inc. · Options to purchase common stockM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−11.7K sh	—	—	0
2024-06-18	CRBPCorbus Pharmaceuticals Holdings, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+1,770 sh	$14.10	+$25K	86,170
2024-06-18	CRBPCorbus Pharmaceuticals Holdings, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,770 sh	$42.24	−$74.8K	84,400
2024-06-18	CRBPCorbus Pharmaceuticals Holdings, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+2,322 sh	$4.26	+$9,891.72	86,722
2024-06-18	CRBPCorbus Pharmaceuticals Holdings, Inc.S Sale	Director, Chief Executive Officer	SSale	−2,322 sh	$42.24	−$98.1K	84,400
2024-06-18	CRBPCorbus Pharmaceuticals Holdings, Inc.S Sale	Director, Chief Executive Officer	SSale	−7,179 sh	$42.24	−$303K	77,221
2024-06-18	CRBPCorbus Pharmaceuticals Holdings, Inc. · Options to purchase common stockM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−2,322 sh	—	—	49,739
2024-06-18	CRBPCorbus Pharmaceuticals Holdings, Inc. · Options to purchase common stockM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−1,770 sh	—	—	31,057
2024-06-17	CRBPCorbus Pharmaceuticals Holdings, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+1,770 sh	$4.26	+$7,540.2	86,170
2024-06-17	CRBPCorbus Pharmaceuticals Holdings, Inc. · Options to purchase common stockM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−9,333 sh	—	—	11,667
2024-06-17	CRBPCorbus Pharmaceuticals Holdings, Inc. · Options to purchase common stockM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−1,770 sh	—	—	52,061
2024-06-17	CRBPCorbus Pharmaceuticals Holdings, Inc.S Sale	Director, Chief Executive Officer	SSale	−9,333 sh	$46.02	−$430K	84,400
2024-06-17	CRBPCorbus Pharmaceuticals Holdings, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+9,333 sh	$30.00	+$280K	93,733
2024-06-17	CRBPCorbus Pharmaceuticals Holdings, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,770 sh	$46.02	−$81.5K	84,400
2024-06-14	CRBPCorbus Pharmaceuticals Holdings, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+16.8K sh	$14.10	+$237K	101,230
2024-06-14	CRBPCorbus Pharmaceuticals Holdings, Inc.S Sale	Director, Chief Executive Officer	SSale	−12.5K sh	$50.17	−$626K	84,400
2024-06-14	CRBPCorbus Pharmaceuticals Holdings, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+12.5K sh	$4.26	+$53.2K	96,887
2024-06-14	CRBPCorbus Pharmaceuticals Holdings, Inc. · Options to purchase common stockM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−12.5K sh	—	—	53,831
2024-06-14	CRBPCorbus Pharmaceuticals Holdings, Inc. · Options to purchase common stockM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−16.8K sh	—	—	32,827
2024-06-14	CRBPCorbus Pharmaceuticals Holdings, Inc.S Sale	Director, Chief Executive Officer	SSale	−16.8K sh	$50.17	−$844K	84,400
2024-02-12	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+73.9K sh	—	—	73,947
2024-02-12	CRBPCorbus Pharmaceuticals Holdings, Inc.A Award	Director, Chief Executive Officer	AAward	+73.9K sh	—	—	84,400
2024-01-26	CRBPCorbus Pharmaceuticals Holdings, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+7,179 sh	$4.97	+$35.7K	7,179
2024-01-26	CRBPCorbus Pharmaceuticals Holdings, Inc. · Options to purchase common stockM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−7,179 sh	$4.97	−$35.7K	0
2023-02-13	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+1.99M sh	—	—	1,949,546
2022-08-10	CRBPCorbus Pharmaceuticals Holdings, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+3,800 sh	$0.26	+$1,003.2	98,230
2022-05-16	CRBPCorbus Pharmaceuticals Holdings, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+10.5K sh	$0.25	+$2,625	94,430
2022-03-09	CRBPCorbus Pharmaceuticals Holdings, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+8,600 sh	$0.37	+$3,182	83,930
2022-02-01	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+1.49M sh	—	—	1,489,700
2021-02-02	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+957K sh	—	—	956,500
2021-02-02	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+957K sh	—	—	956,500
2020-11-11	CRBPCorbus Pharmaceuticals Holdings, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+4,240 sh	$1.21	+$5,126.16	75,330
2020-03-17	CRBPCorbus Pharmaceuticals Holdings, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+4,300 sh	$3.49	+$15K	71,090
2020-03-06	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock Option(right to buy)A Award	Director, Chief Executive Officer	AAward	+639K sh	—	—	639,000
2019-11-12	CRBPCorbus Pharmaceuticals Holdings, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+1,430 sh	$4.26	+$6,091.8	66,790

Recent filings

Accepted (ET)
Aug 104
Cohen Yuval0001193125-26-342485
SEC(opens sec.gov)
Feb 184
Cohen Yuval0001193125-26-057159
SEC(opens sec.gov)
Jan 164
Cohen Yuval0001193125-26-015426
SEC(opens sec.gov)
Oct 274
Cohen Yuval0001193125-25-251639
SEC(opens sec.gov)
Feb 184
Cohen Yuval0000950170-25-022512
SEC(opens sec.gov)
Feb 44
Cohen Yuval0000950170-25-013697
SEC(opens sec.gov)
Jun 184
Cohen Yuval0000950170-24-075071
SEC(opens sec.gov)

Companies

Corbus Pharmaceuticals Holdings, Inc.Director, Chief Executive OfficerCRBP

Address

C/O CORBUS PHARMACEUTICALS HOLDINGS, INC 500 RIVER RIDGE DRIVE

NORWOOD, MA, 02062